97 related articles for article (PubMed ID: 31619772)
1. Bactericidal effect of pyridine-2-thiol 1-oxide sodium salt and its complex with iron against resistant clinical isolates of Mycobacterium tuberculosis.
Campos DL; Machado I; Ribeiro CM; Gambino D; Pavan FR
J Antibiot (Tokyo); 2020 Feb; 73(2):120-124. PubMed ID: 31619772
[TBL] [Abstract][Full Text] [Related]
2. Bioactivity of pyridine-2-thiolato-1-oxide metal complexes: Bi(III), Fe(III) and Ga(III) complexes as potent anti-Mycobacterium tuberculosis prospective agents.
Machado I; Marino LB; Demoro B; Echeverría GA; Piro OE; Leite CQ; Pavan FR; Gambino D
Eur J Med Chem; 2014 Nov; 87():267-73. PubMed ID: 25261824
[TBL] [Abstract][Full Text] [Related]
3. Activity of rifampicin and linezolid combination in Mycobacterium tuberculosis.
Maltempe FG; Caleffi-Ferracioli KR; do Amaral RCR; de Oliveira Demitto F; Siqueira VLD; de Lima Scodro RB; Hirata MH; Pavan FR; Cardoso RF
Tuberculosis (Edinb); 2017 May; 104():24-29. PubMed ID: 28454646
[TBL] [Abstract][Full Text] [Related]
4. Linked pyridinyl-thiadiazoles: Design and synthesis as potential candidate for treatment of XDR and MDR tuberculosis.
Mahajan NS; Dhawale SC
Eur J Med Chem; 2015 Sep; 102():243-8. PubMed ID: 26280920
[TBL] [Abstract][Full Text] [Related]
5. Comparison of
Zong Z; Jing W; Shi J; Wen S; Zhang T; Huo F; Shang Y; Liang Q; Huang H; Pang Y
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844043
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Polyphenolic Profile and Antibacterial Activity of Pomegranate Juice in Combination with Rifampin (R) against MDR-TB Clinical Isolates.
AlMatar M; Var I; Kayar B; Eker E; Kafkas E; Zarifikhosroshahi M; Köksal F
Curr Pharm Biotechnol; 2019; 20(4):317-326. PubMed ID: 30854955
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of (-)-deoxypergularinine, on its own and in combination with anti-tubercular drugs, against resistant strains of Mycobacterium tuberculosis.
Nam KW; Jang WS; Jyoti MA; Kim S; Lee BE; Song HY
Phytomedicine; 2016 May; 23(5):578-82. PubMed ID: 27064017
[TBL] [Abstract][Full Text] [Related]
8. Copper-related toxicity in replicating and dormant Mycobacterium tuberculosis caused by 1-hydroxy-5-R-pyridine-2(1H)-thiones.
Salina EG; Huszár S; Zemanová J; Keruchenko J; Riabova O; Kazakova E; Grigorov A; Azhikina T; Kaprelyants A; Mikušová K; Makarov V
Metallomics; 2018 Jul; 10(7):992-1002. PubMed ID: 29946601
[TBL] [Abstract][Full Text] [Related]
9. In vitro bactericidal activity of 3-cinnamoyl-4-hydroxy-6-methyl-2-pyrone (CHP) against drug-susceptible, drug-resistant and drug-tolerant isolates of Mycobacterium tuberculosis.
Bhat ZS; Rather MA; Ul Lah H; Hussain A; Maqbool M; Yousuf SK; Jabeen Z; Wani MA; Ahmad Z
J Glob Antimicrob Resist; 2020 Sep; 22():57-62. PubMed ID: 31809940
[TBL] [Abstract][Full Text] [Related]
10. In vitro interaction profiles of the new antitubercular drugs bedaquiline and delamanid with moxifloxacin against clinical Mycobacterium tuberculosis isolates.
Chandramohan Y; Padmanaban V; Bethunaickan R; Tripathy S; Swaminathan S; Ranganathan UD
J Glob Antimicrob Resist; 2019 Dec; 19():348-353. PubMed ID: 31226332
[TBL] [Abstract][Full Text] [Related]
11. [In Vitro Effect of Ankaferd Blood Stopper®, a Plant Extract Against Mycobacterium tuberculosis Isolates].
Deveci A; Coban AY; Tanrıverdi Çaycı Y; Acicbe O; Taşdelen Fışgın N; Akgüneş A; Ozatlı D; Uzun M; Durupınar B
Mikrobiyol Bul; 2013 Jan; 47(1):71-8. PubMed ID: 23390904
[TBL] [Abstract][Full Text] [Related]
12. Antimycobacterial activity of Citrullus colocynthis (L.) Schrad. against drug sensitive and drug resistant Mycobacterium tuberculosis and MOTT clinical isolates.
Mehta A; Srivastva G; Kachhwaha S; Sharma M; Kothari SL
J Ethnopharmacol; 2013 Aug; 149(1):195-200. PubMed ID: 23816500
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of dinactin, a potent microbial metabolite against Mycobacterium tuberculosis.
Hussain A; Rather MA; Bhat ZS; Majeed A; Maqbool M; Shah AM; Aga MA; Shah A; Mushtaq S; Sangwan PL; Hassan QP; Ahmad Z
Int J Antimicrob Agents; 2019 Jan; 53(1):49-53. PubMed ID: 30267759
[TBL] [Abstract][Full Text] [Related]
14. A green expedient synthesis of pyridopyrimidine-2-thiones and their antitubercular activity.
Rajesh SM; Kumar RS; Libertsen LA; Perumal S; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2011 May; 21(10):3012-6. PubMed ID: 21498077
[TBL] [Abstract][Full Text] [Related]
15. Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China.
Zhang Z; Pang Y; Wang Y; Liu C; Zhao Y
Int J Antimicrob Agents; 2014 Mar; 43(3):231-5. PubMed ID: 24439458
[TBL] [Abstract][Full Text] [Related]
16. Expression analysis of 10 efflux pump genes in multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis clinical isolates.
Kardan-Yamchi J; Kazemian H; Haeili M; Harati AA; Amini S; Feizabadi MM
J Glob Antimicrob Resist; 2019 Jun; 17():201-208. PubMed ID: 30654147
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of novel imidazo[1,2-a]pyridinecarboxamides as potent anti-tuberculosis agents.
Onajole OK; Lun S; Yun YJ; Langue DY; Jaskula-Dybka M; Flores A; Frazier E; Scurry AC; Zavala A; Arreola KR; Pierzchalski B; Ayitou AJ; Bishai WR
Chem Biol Drug Des; 2020 Dec; 96(6):1362-1371. PubMed ID: 32515129
[TBL] [Abstract][Full Text] [Related]
18. Exploiting the furo[2,3-b]pyridine core against multidrug-resistant Mycobacterium tuberculosis.
Fumagalli F; de Melo SMG; Ribeiro CM; Solcia MC; Pavan FR; da Silva Emery F
Bioorg Med Chem Lett; 2019 Apr; 29(8):974-977. PubMed ID: 30803803
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages.
Rastogi N; Labrousse V; Goh KS
Curr Microbiol; 1996 Sep; 33(3):167-75. PubMed ID: 8672093
[TBL] [Abstract][Full Text] [Related]
20. In vitro anti-tuberculosis activity of azole drugs against Mycobacterium tuberculosis clinical isolates.
Imperiale BR; Cataldi ÁA; Morcillo NS
Rev Argent Microbiol; 2017; 49(4):332-338. PubMed ID: 28919150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
